Companies / Bicara Therapeutics Inc.
Bicara Therapeutics Inc.
Nasdaq: BCAXCIK 2023658BOSTON, MA
Financials
Ownership
66.2M shares outstanding · as of Aug 6, 2026
Ownership
| Insiders | 8.08% | 5,344,092 |
| 10%+ / strategic | 14.11% | 9,333,818 |
| Institutions | 68.61% | 45,400,517 |
| Public float | 9.21% | 6,094,507 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 11
View all →| Insider | % of shares | Shares |
|---|---|---|
RA Capital Management, L.P.Director · 10% owner | 6.96% | 4,603,418 |
Mazumdar ClaireCEOChief Executive Officer · Director | 0.51% | 339,392 |
Cohlhepp RyanPresident and COO · Director | 0.30% | 200,641 |
Hyep IvanChief Financial Officer | 0.22% | 145,355 |
Raben DavidChief Medical Officer | 0.08% | 55,286 |
Kolchinsky PeterDirector · 10% owner | — | — |
Meisner LaraChief Legal Officer | — | — |
Powell MichaelDirector | — | — |
RA Capital Healthcare Fund LPDirector · 10% owner | — | — |
RA Capital Nexus Fund III, L.P.Director | — | — |
Institutional holders 147
View all →| Holder | Value | % of shares |
|---|---|---|
| $144.32M | 10.97% | |
| $114.25M | 5.82% | |
| $87.80M | 7.88% | |
| $66.35M | 5.05% | |
| $60.83M | 3.10% | |
| $60.17M | 5.40% | |
| $56.33M | 5.06% | |
| $53.36M | 4.79% | |
| $50.67M | 4.55% | |
| $43.99M | 3.95% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | — | $39.18M | +1.3M +52.19% | 3,848,090 5.82% of shares | medium |
| Q1 2026 as of | Janus Henderson Group PLC 13F manager | Add | — | $13.77M | +693K +26.19% | 3,339,218 5.05% of shares | medium |
| Q2 2026 as of | State Street Corporation 13F manager | Add | — | $11.86M | +399K +24.21% | 2,048,920 3.10% of shares | medium |
| Q1 2026 as of | Orbimed Advisors LLC 13F manager | Add | — | $9.11M | +458K +219.13% | 667,300 1.01% of shares | medium |
| Q1 2026 as of | RA Capital Management, L.P. 13F manager | Add | — | $5.97M | +300K +4.31% | 7,255,993 10.97% of shares | medium |
| Q1 2026 as of | Millennium Management LLC 13F manager | Trim | — | $-5.53M | -278K -63.95% | 156,702 0.24% of shares | medium |
| Q1 2026 as of | Palo Alto Investors LP 13F manager | Add | — | $5.01M | +252K +84.34% | 550,408 0.83% of shares | medium |
| Q1 2026 as of | DAFNA Capital Management LLC 13F manager | Add | — | $3.19M | +160K +61.22% | 421,733 0.64% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Deep Track Capital, LP | Passive13G | — |
| T. Rowe Price Investment Management, Inc. | Passive13G | — |
| Vestal Point Capital, LP | Passive13G/A | — |
| Fmr LLC | Passive13G/A | — |
| Janus Henderson Group PLC | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| BCAX | — | 055477103 |